title: Mycoplasma genitalium testing pattern and macrolide resistance: a Danish nationwide retrospective survey.
abstract: BACKGROUND
  Mycoplasma genitalium is a common cause of nongonococcal urethritis (NGU) and cervicitis. The aim of the study was to analyze the M. genitalium testing pattern and distribution of positive results according to sex and age in a 5-year period where all diagnostic M. genitalium testing in Denmark was centralized at the Statens Serum Institut. A secondary aim was to estimate the occurrence of macrolide resistance in a 3-year period.
  
  
  METHODS
  The study was performed as a nationwide retrospective survey of specimens submitted from general practice, private specialists, and hospitals to Statens Serum Institut for detection of M. genitalium by polymerase chain reaction between 1 January 2006 and 31 December 2010. Macrolide resistance screening was introduced December 2007.
  
  
  RESULTS
  A total of 31 600 specimens from 28 958 patients were tested for M. genitalium, with an increasing trend from 3858 per year in 2006 to 7361 in 2010. The majority (54%) of the patients were tested in general practice. For both sexes, the positive rate increased significantly, from 2.4% to 3.8% for women and from 7.9% to 10.3% for men (P < .0005). Macrolide resistance was detected in 38% (385/1008) of the M. genitalium-positive patients, and the highest rate was found in patients tested at sexually transmitted disease clinics (43%).
  
  
  CONCLUSIONS
  Testing for M. genitalium has become important for clinicians treating sexually transmitted infections. In this nationwide survey, macrolide resistance was found in almost 40% of the specimens, raising concern about single-dose azithromycin treatment of NGU, and emphasizing that NGU treatment should be guided by etiologic diagnosis.
authors.affiliation: Microbiology and Infection Control, Sexually Transmitted Infections, Research and Development, Statens Serum Institut, Copenhagen, Denmark.
authors.forename: Kirsten
authors.initials: K
authors.lastname: Salado-Rasmussen
authors.affiliation: Microbiology and Infection Control, Sexually Transmitted Infections, Research and Development, Statens Serum Institut, Copenhagen, Denmark.
authors.forename: Jørgen Skov
authors.initials: JS
authors.lastname: Jensen
mesh_terms: D000293:Adolescent; D000328:Adult; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D004269:DNA, Bacterial / Q000235:genetics; D003718:Denmark / Q000453:epidemiology; D024881:Drug Resistance, Bacterial; D005260:Female; D005838:Genotype; D060005:Genotyping Techniques; D006801:Humans; D018942:Macrolides / Q000494:pharmacology*; D008297:Male; D008875:Middle Aged; D009175:Mycoplasma Infections / Q000453:epidemiology / Q000382:microbiology*; D045704:Mycoplasma genitalium / Q000187:drug effects*; D016133:Polymerase Chain Reaction; D015995:Prevalence; D012336:RNA, Ribosomal, 16S / Q000235:genetics; D012338:RNA, Ribosomal, 23S / Q000235:genetics; D012189:Retrospective Studies; D017422:Sequence Analysis, DNA; D055815:Young Adult
chemical_list: D000900:Anti-Bacterial Agents; D004269:DNA, Bacterial; D018942:Macrolides; D012336:RNA, Ribosomal, 16S; D012338:RNA, Ribosomal, 23S
keywords: Mycoplasma genitalium; macrolide resistance; prevalence
references.citation: Emerg Infect Dis. 2006 Jul;12(7):1149-52
references.pmid: 16836839
references.citation: Clin Infect Dis. 2008 Dec 15;47(12):1546-53
references.pmid: 18990060
references.citation: Sex Transm Infect. 2005 Feb;81(1):73-8
references.pmid: 15681728
references.citation: Clin Infect Dis. 2009 Jun 15;48(12):1649-54
references.pmid: 19438399
references.citation: Int J STD AIDS. 2008 Oct;19(10):676-9
references.pmid: 18824619
references.citation: Hum Reprod. 2001 Sep;16(9):1866-74
references.pmid: 11527890
references.citation: Sex Transm Infect. 2009 Oct;85(6):436-7
references.pmid: 19587392
references.citation: Clin Infect Dis. 2010 Nov 15;51(10):1160-6
references.pmid: 20942656
references.citation: J Clin Microbiol. 2006 Jun;44(6):2078-83
references.pmid: 16757601
references.citation: J Clin Microbiol. 2013 Jul;51(7):2245-9
references.pmid: 23658265
references.citation: Sex Transm Infect. 2003 Apr;79(2):154-6
references.pmid: 12690141
references.citation: Int J STD AIDS. 2013 Oct;24(10):822-8
references.pmid: 24052013
references.citation: Sex Transm Infect. 2007 Jun;83(3):237-41
references.pmid: 17090566
references.citation: Am J Obstet Gynecol. 2012 Jun;206(6):476.e1-8
references.pmid: 22483084
references.citation: Fertil Steril. 2008 Sep;90(3):513-20
references.pmid: 17548070
references.citation: Lancet. 2002 Mar 2;359(9308):765-6
references.pmid: 11888591
references.citation: Methods Mol Biol. 2012;903:129-39
references.pmid: 22782815
references.citation: Clin Infect Dis. 2014 Mar;58(5):631-7
references.pmid: 24280088
references.citation: BJOG. 2010 Feb;117(3):361-4
references.pmid: 20015303
references.citation: Clin Microbiol Rev. 2011 Jul;24(3):498-514
references.pmid: 21734246
references.citation: J Eur Acad Dermatol Venereol. 2004 Jan;18(1):1-11
references.pmid: 14678525
references.citation: BMC Infect Dis. 2011 Feb 01;11:35
references.pmid: 21284887
references.citation: Clin Infect Dis. 2013 Apr;56(7):934-42
references.pmid: 23223595
references.citation: Sex Transm Infect. 2004 Aug;80(4):289-93
references.pmid: 15295128
references.citation: Int J Circumpolar Health. 2012 Apr 16;71:1-8
references.pmid: 22564463
references.citation: Clin Infect Dis. 2013 Apr;56(8):1094-100
references.pmid: 23300236
references.citation: Sex Transm Infect. 2008 Feb;84(1):72-6
references.pmid: 17932127
references.citation: Sex Transm Infect. 2013 Aug;89(5):372-6
references.pmid: 23270933
references.citation: J Clin Microbiol. 2004 Feb;42(2):683-92
references.pmid: 14766837
references.citation: PLoS One. 2013 Apr 08;8(4):e61481
references.pmid: 23593483
references.citation: J Clin Microbiol. 2003 Jan;41(1):261-6
references.pmid: 12517858